Area of research
Modeling and Simulation · Oncology
Research interest
Research interests include Mathematical Biology Tumor Growth, Nanoparticle-Based Drug Delivery, Cancer Immunotherapy and Biomarkers, and Cancer Cells and Metastasis.
Trastuzumab rezetecan, a HER2-directed antibody–drug conjugate, in patients with advanced HER2-mutant non-small-cell lung cancer (HORIZON-Lung): phase 2 results from a multicentre, single-arm study
Rational Design of Safer Inorganic Nanoparticles via Mechanistic Modeling-Informed Machine Learning
Hybridizing mechanistic modeling and deep learning for personalized survival prediction after immune checkpoint inhibitor immunotherapy
Ceramide as an endothelial cell surface receptor and a lung-specific lipid vascular target for circulating ligands
Combined Age with Mean Decrease Rates of Total Bilirubin and MELD Score as a Novel and Simple Clinical Predictor on 90-Day Transplant-Free Mortality in Adult Patients with Acute Liver Failure Undergoing Plasma Exchange: A Single-Center Retrospective Study
Mathematical modeling of cancer immunotherapy for personalized clinical translation
Targeting a cell surface vitamin D receptor on tumor-associated macrophages in triple-negative breast cancer
Amphibian regeneration and mammalian cancer: Similarities and contrasts from an evolutionary biology perspective
Early prediction of clinical response to checkpoint inhibitor therapy in human solid tumors through mathematical modeling
Author response: Early prediction of clinical response to checkpoint inhibitor therapy in human solid tumors through mathematical modeling
Innate Immunity Plays a Key Role in Controlling Viral Load in COVID-19: Mechanistic Insights from a Whole-Body Infection Dynamics Model
Prognostic value of TP53 co-mutation status combined with EGFR mutation in patients with lung adenocarcinoma
Targeted phage display-based pulmonary vaccination in mice and non-human primates
Predicting breast cancer response to neoadjuvant chemotherapy based on tumor vascular features in needle biopsies